In a similar fashion, a review performed on pediatric studies that enrolled patients diagnosed with heart failure concluded that none of the currently available serum biomarkers of myocardial fibrosis perform as well as NT-proBNP in predicting ventricular dysfunction [64]. The gene discussed is NPPB; the disease is Myocardial fibrosis.